share_log

NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-CHIEF FINANCIAL OFFICER VAN VOORHEES SETH

Dec 19, 2022 07:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more